Antibody-drug conjugates in NSCLC with actionable genomic alterations: Optimizing smart delivery of chemotherapy to the target
Giannis Mountzios, Stephanie P.L. Saw, Lizza Hendriks, Jessica Menis, Tina Cascone, Óscar Arrieta, Jarushka Naidoo, Prodromos Koutoukoglou, Massimiliano Cani, Antoine Lefèvre, Alfredo Addeo, Solange Peters, Jordi Remón
Topics & Concepts
MedicineDrugAntibody-drug conjugateChemotherapyDrug deliveryConjugateAntibodyPharmacologyCancer researchImmunologyMonoclonal antibodyInternal medicineMathematical analysisOrganic chemistryChemistryMathematicsHER2/EGFR in Cancer ResearchLung Cancer Treatments and MutationsMonoclonal and Polyclonal Antibodies Research